Immunologist Thomas Hodge Dies of COVID-19 at 69

A former academic and consultant, Hodge cofounded the CrisiScience Collective to help combat the pandemic.

| 2 min read
Middle aged man with glasses wearing a blue shirt and tan blazer with a red paisley tie looking into the camera

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © CHARLES WARDEN, ETSU

Immunologist and virologist Thomas Hodge III died on July 31 due to complications of COVID-19. He was 69. According to The Washington Post, Hodge was medically ineligible to be vaccinated against the disease.

Born and raised in Gainesville, Georgia, Hodge graduated from Emory University in nearby Atlanta in 1974, where he double-majored in biology and chemistry, according to his CV. He received his PhD in immunology from East Tennessee State University College of Medicine in 1982.

After graduation, he worked as an assistant professor of microbiology at the University of Alabama, Birmingham School of Medicine for four years, before leaving to join the US Centers for Disease Control and Prevention (CDC). Hodge was the section chief of molecular immunology in the division of HIV/AIDS pathogenesis at the CDC until 1993 when he took over as the division’s director of the immunogenetics laboratory, where he stayed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Lisa Winter

    Lisa Winter became social media editor for The Scientist in 2017. In addition to her duties on social media platforms, she also pens obituaries for the website. She graduated from Arizona State University, where she studied genetics, cell, and developmental biology.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio